"Our society and our medical community has basically thrown up their hands and decided it is too hard to get people to lead healthier lives, and it is easier to push drugs," said Michael Jacobsen, executive director of the Center for Science in the Public Interest.
Sales of diabetes-treatment products total about $8 billion a year in the U.S., according to pharmaceutical research firm IMS Health Inc., and drug makers spend close to $1 billion promoting their goods to doctors and patients.